Welcome to our dedicated page for Neolara SEC filings (Ticker: NELR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Neolara Corp (NELR) filings submitted to the U.S. Securities and Exchange Commission, including current reports on Form 8-K. These documents disclose material events such as changes in control of the registrant and shifts in the composition of its executive team and board of directors.
In an 8-K dated September 19, 2025, Neolara Corp reported a stock purchase agreement involving 2,000,000 shares of common stock, representing approximately 63% of the issued and outstanding shares as of that date. The filing explains that this transaction gave the buyer the ability to control the election of the board and other matters requiring shareholder approval. It also details the resignation of prior officers and directors and the appointment of a new Chief Executive Officer, Chief Financial Officer, Secretary, and sole Director.
Neolara Corp’s filings also include biographical information about its officers and directors, outlining experience in architectural design and construction, biomedical engineering, and software development, along with related academic degrees. These disclosures help readers understand the qualifications and professional histories of the individuals guiding the company.
On Stock Titan, Neolara Corp’s SEC filings are paired with AI-powered summaries that explain the key points of each document in plain language. Users can quickly see what a filing covers, why a change in control or management matters, and which sections may warrant deeper review, without reading every line of the underlying text.
Neolara Corp. filed a Rule 12b-25 notification stating it cannot timely file its Form 10-Q for the period ended December 31, 2025 because it requires additional time for review by its independent accountant. The notification was signed by Cao Wei on April 3, 2026.
Neolara Corp. notified the SEC that it could not timely file its Form 10-Q for the period ended December 31, 2025 because the company "requires additional time to have its quarterly report on Form 10-Q reviewed by its independent accountant." The notice was signed on February 17, 2026.
Neolara Corp. reported a change in control and executive leadership. The previous CEO, director and majority shareholder sold 2,000,000 shares of Common Stock, representing approximately 63% of the issued and outstanding shares, to Cao Wei, giving Mr. Cao the ability to unilaterally control board elections and other shareholder matters. The prior CEO resigned from all executive and board positions. Effective the same day, Cao Wei was appointed Chief Executive Officer, Chief Financial Officer, Secretary and sole Director.
Neolara Corp. reported limited operating scale with $20,719 in current assets and a reported net loss of $23,688 for the year ended June 30, 2025. The company shows a stockholders' deficit of $(23,343) and a net decrease in cash and cash equivalents of $28,311, reflecting cash outflows during the period. Management issued 1,127,000 shares of common stock for proceeds totaling $33,810, and intangible assets are being amortized with annual amortization expense of $2,750. Related-party borrowings include a non-interest-bearing, demand loan of $90,713. The filing discloses material internal control weaknesses over cash and information technology and notes no identified cybersecurity incidents that materially affected the business. Overall, the company has limited working capital and has not established stable revenue sufficient to cover ongoing operating costs.